Rukmini Kumar
71 posts
Rukmini Kumar
@Rukmini_Vantage
Chief Scientist, Vantage Research
Katılım Kasım 2021
101 Takip Edilen108 Takipçiler
@mkjolly15 @official_ibab @biopatrika @rakeshthejoy @UjjainiDasgupt2 @Bio_IISc @SharmilaBapat @shruthy_suresh @BhallaSherry @geethamhp @niramaianalytix @IndiaBioscience @VoicesofIndAcad Fantastic job getting this together @mkjolly15 & @official_ibab - so excited to see this!
English
Rukmini Kumar retweetledi
Excited to organize with Prof. V Mahadevan @official_ibab a symposium highlighting the women speakers investigating cancer as a complex system. Poster session, panel discussion, hands-on training on AI/ML in genomics too! Registration deadline: June 25.
@biopatrika @rakeshthejoy
English
Rukmini Kumar retweetledi
Join us for an intriguing journey into the world of cancer research with @mkjolly15! Mark your calendars for March 17th, Sunday at 4 PM, and head over to the @JNPlanetarium for Kaapi with Kuriosity talks.
Register: bit.ly/kwk_mar2024
English
Rukmini Kumar retweetledi
Rukmini Kumar retweetledi
Schedule for @ictstifr meeting on mathematical oncology, co-organized together with @shaon_chak, Helen Byrne @OxUniMaths, Franziska Michor @DanaFarber. Thanks to Param Hansa Philanthropies @rakeshthejoy for co-sponsoring it. Excited for these 2 weeks of stimulating discussion.
English
Thanks for the kind words @KasturiMahadik . Comp bio applied to drug development is exciting and we are always happy to share our excitement :)
Scientist By The Side 👩🏾@KasturiMahadik
Rukmini and Vikram are so well-spoken about the whys and hows of computational biology in drug development. Don't hesitate to take the opportunity to talk with them! Register today!! @cphms_aic @Rukmini_Vantage
English
@Himanshu_IITM @Garbhinicohort @THSTIFaridabad @Shinjini_Bhtngr @rcthiru @DBTIndia @BIRAC_2012 Congrats @Himanshu_IITM, @Shinjini_Bhtngr @rcthiru, IITM & THSTI teams for this impactful work!
English
Exciting outcome from @Garbhinicohort & deep collaboration w/ @THSTIFaridabad @Shinjini_Bhtngr @rcthiru can potentially transform prenatal care & birth outcomes. Time to quickly validate & use the Garbhini-GA2 model in Indian settings. Thanks 2 @DBTIndia @BIRAC_2012 for funding
The Lancet Reg Health-Southeast Asia@LancetRH_SEAsia
Most widely used #Hadlock formula performed poorly in Indian settings. Garbhini-GA2 model, which uses routinely measured #foetal biometry, can be swiftly adopted for clinical purposes across the Indian subcontinent after a pan-#India validation Read more bit.ly/3Igi5pi
English
Insights into the immunological signature of Chronic Hepatitis B and functional cure. Years of hardwork, some great science and collaborations. @DasguptaRam @Niranjan_says @SengGeeLim1 @KhAk_AaT @giridharanperi2 #Hepatitisb @JHepatology #singlecell #immune @astar_research
English
Rukmini Kumar retweetledi
Don' miss the February Webinar: 'The Long Road from Discovery to Design' by Brian Topp, Merck. February 21, 9 am PST. Register at buff.ly/3Hry0QS
English
Congratulations Mohit and team!
Mohit Kumar Jolly@mkjolly15
Humbled to receive the ICTP 2023 Prize for our work on decoding the dynamics of cancer cell-state transitions. Grateful to all my mentors, collaborators, current & past students and those who nominated me ictp.it/news/2023/11/i… @ictpnews @BE_IISc @Physics_at_IISc @iiscbangalore
English
So happy for your momentum in bringing all this together @mkjolly15 and looking forward to supporting any way I can!
Mohit Kumar Jolly@mkjolly15
Thrilled to lead the Centre for Computational Oncology at @iiscbangalore, generously supported by Param Hansa Philanthropies @dheeraj @rakeshthejoy, with the aim of impacting cancer care & building a generation of computational oncology community in India. researchmatters.in/news/param-han…
English
Indeed! Thanks @areejitsamal and @IMScChennai colleagues for your hospitality. Lovely to meet with the friendly biological modeling community.
Mohit Kumar Jolly@mkjolly15
Had an excellent time at this stimulating meeting organised by @areejitsamal @IMScChennai. Great to meet friends working on network biology & getting their feedback on our recent work. @rsidd120 @karthikraman @Rukmini_Vantage @r_sabarinathan @sci_abhishek @artanumus @gansbags
English
* Demonstrating this using data
-> pubmed.ncbi.nlm.nih.gov/37699333/
-> pubmed.ncbi.nlm.nih.gov/34543717/
* Modeling approach
-> pubmed.ncbi.nlm.nih.gov/33938166/
* Opinion piece on impact on drug development
-> pubmed.ncbi.nlm.nih.gov/37350966/
English
New paper alert from Vantage & Merck & collaborators (pubmed.ncbi.nlm.nih.gov/37699333/) This adds to the work on the importance of lesion-to-lesion heterogeneity in response to Checkpoint Rx, that we have collaborated with Brian Topp & colleagues at @Merck
English
Excited to be part of this! Thanks for the invitation @areejitsamal !
Areejit Samal@areejitsamal
Excited to announce the upcoming meeting "Modelling and Tackling Complex Biological Systems" @IMScChennai on 13-14 Oct 2023 @rsidd120 @gansbags @karthikraman @mkjolly15 @r_sabarinathan @dhirajverma @caps_ncbs @Rukmini_Vantage @sci_abhishek @artanumus @dineshgupt
English
Rukmini Kumar retweetledi
Undoubtedly he was a pioneer, a visionary who could see the importance of diabetes much before others realised it. His contributions are path breaking. I am sure he will be proud of the way in which you and the family have built upon his foundation, and placed India on the world stage in diabetes research! Respects 🙏
English
Rukmini Kumar retweetledi
Chandrayaan-3 Mission:
'India🇮🇳,
I reached my destination
and you too!'
: Chandrayaan-3
Chandrayaan-3 has successfully
soft-landed on the moon 🌖!.
Congratulations, India🇮🇳!
#Chandrayaan_3
#Ch3
English